111 related articles for article (PubMed ID: 2703390)
61. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409
[TBL] [Abstract][Full Text] [Related]
62. 5-chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and Lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice.
Greer S; Santos O; Gottlieb C; Schwade J; Marion HS
Int J Radiat Oncol Biol Phys; 1992; 22(3):505-10. PubMed ID: 1735688
[TBL] [Abstract][Full Text] [Related]
63. [
Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
[TBL] [Abstract][Full Text] [Related]
64. A phase I study of the hypoxic cell radiosensitizer Ro-03-8799.
Roberts JT; Bleehen NM; Workman P; Walton MI
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1755-8. PubMed ID: 6480458
[TBL] [Abstract][Full Text] [Related]
65. Anti-melanin deposition activity of ceramicines from Chisocheton ceramicus.
Iijima C; Wong CP; Nugroho AE; Sotozono Y; Someya S; Hirasawa Y; Kaneda T; Hadi AH; Morita H
J Nat Med; 2016 Oct; 70(4):702-7. PubMed ID: 27357963
[TBL] [Abstract][Full Text] [Related]
66. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
[TBL] [Abstract][Full Text] [Related]
67. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
Sunkara PS; Bowlin TL; Rosenberger AL; Fleischmann WR
J Biol Response Mod; 1989 Apr; 8(2):170-9. PubMed ID: 2499664
[TBL] [Abstract][Full Text] [Related]
68. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
[TBL] [Abstract][Full Text] [Related]
69. Influence of melanoma B16 on the pharmacokinetics of mitoguazone in mice.
Amlacher R; Baumgart J; Mackowiak A; Sühnel J; Horn U; Bubner M; Hoffmann H
Pharmazie; 1991 Jan; 46(1):44-6. PubMed ID: 1857730
[TBL] [Abstract][Full Text] [Related]
70. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.
Fowler JF; Sheldon PW; Denekamp J; Field SB
Int J Radiat Oncol Biol Phys; 1976; 1(7-8):579-92. PubMed ID: 977399
[No Abstract] [Full Text] [Related]
71. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
Tada T; Nakajima T; Onoyama Y; Murayama C; Mori T; Nagasawa H; Hori H; Inayama S
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):601-5. PubMed ID: 8005823
[TBL] [Abstract][Full Text] [Related]
72. [Photodynamic therapy of zinc sulfonated phthalocyanine on murine transplanted tumors, its tissue distribution, and damaging effect on DNA of cancer cell].
Fu NW; Guo R; Yan LX; Huang L; Xu HJ
Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):457-61. PubMed ID: 1819903
[TBL] [Abstract][Full Text] [Related]
73. Biochemical Characterization of Ferulic Acid and Caffeic Acid Which Effectively Inhibit Melanin Synthesis via Different Mechanisms in B16 Melanoma Cells.
Maruyama H; Kawakami F; Lwin TT; Imai M; Shamsa F
Biol Pharm Bull; 2018; 41(5):806-810. PubMed ID: 29709918
[TBL] [Abstract][Full Text] [Related]
74. A multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
Bleehen NM; Newman HF; Maughan TS; Workman P
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1093-6. PubMed ID: 2539346
[TBL] [Abstract][Full Text] [Related]
75. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
Schweitzer AD; Rakesh V; Revskaya E; Datta A; Casadevall A; Dadachova E
Melanoma Res; 2007 Oct; 17(5):291-303. PubMed ID: 17885584
[TBL] [Abstract][Full Text] [Related]
76. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
77. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
Shamay Y; Golan M; Tyomkin D; David A
J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
[TBL] [Abstract][Full Text] [Related]
78. Paramagnetic metal scavenging by melanin: MR imaging.
Enochs WS; Petherick P; Bogdanova A; Mohr U; Weissleder R
Radiology; 1997 Aug; 204(2):417-23. PubMed ID: 9240529
[TBL] [Abstract][Full Text] [Related]
79. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
80. EFFECT OF FUCOIDAN ON B16 MURINE MELANOMA CELL MELANIN FORMATION AND APOPTOSIS.
Wang ZJ; Xu W; Liang JW; Wang CS; Kang Y
Afr J Tradit Complement Altern Med; 2017; 14(4):149-155. PubMed ID: 28638878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
